David D. O'Toole, Chief Financial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 541 shares at $20.26 ($11K) on 2023-01-27, disclosed to the SEC on 2023-01-31.
Seasonal sale ($11k) by Chief Financial Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RCEL | BUY | 2026-03-11 | $9K | — | Filing → |
| RCEL | BUY | 2026-02-23 | $12K | — | Filing → |
| RCEL | BUY | 2025-08-26 | $9K | — | Filing → |